Novel serine protease bssp5
CA 2350227 C · Owner: Uemura, Hidetoshi · Inventors: Yamaguchi, Nozomi; Uemura, Hidetoshi; Okui, Akira
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
There are provided proteins having amino acid sequences represented by SEQ ID NOS: 2 and 4; proteins having amino acid sequences derived from these amino acid sequences by deletion, substitution or addition of one to several amino acids; and nucleotide sequences encoding the same; transgenic non-human animals with altered expression level of a serine protease BSSP5; an antibody against BSSP5; and a method for detecting BSSP5 in a specimen using the antibody. The BSSP5 provided by the present invention can be used for treating and diagnosing various diseases such as Alzheimer's disease (AD) epilepsy, cancer, inflammation, sterility and prostatic hypertropy and for detecting …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 19, 1999 and granted July 3, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 19, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 19, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.